CLOs on the Move

Tapinator

www.tapinator.com

 
Tapinator (Ticker: TAPM) is a global developer and publisher of mobile games on the iOS, Google Play, and Amazon platforms. The Company focuses on operating its own titles, publishing properties where it holds substantial ownership positions, and making strategic investments into promising mobile companies. Tapinator’s owned and operated portfolio includes over 55 mobile gaming titles that, collectively, have over 30 million users. A number of these titles have risen to the top of the mobile leaderboard charts and have been featured by the Apple, Google, and Amazon App Stores. Founded in 2013, Tapinator is headquartered in New York, with development ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.tapinator.com
  • 140 West 57th Street; Suite 9C
    New York, NY USA 10019
  • Phone: 914.930.6232

Executives

Name Title Contact Details

Similar Companies

The Physicians Eye Care Center of America

The Physicians Eye Care Center of America is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Brooklyn United Methodist Church Home

Brooklyn United Methodist Church Home is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Brooklyn, NY. To find more information about Brooklyn United Methodist Church Home, please visit www.bumch.org

Eastern Health

Eastern Health is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Eastern Health is based in St. John'S, NL. You can find more information on Eastern Health at www.easternhealth.ca

Deborah Heart and Lung Center

Deborah Heart and Lung Center was established in 1922 as a tuberculosis sanitarium and pulmonary center. Legend has it that Deborah's rural Burlington County location was the key to recovery because of its therapeutic Jersey pine barren air.

Kedrion

Kedrion Biopharma develops and produces plasma-derived therapies, making them available to meet patients` needs the world over. We collect and fractionate blood plasma for the development, production and distribution of plasma derivatives used in the treatment of patients suffering from rare and chronic conditions such as hemophilia and immune system deficiencies. A corporation is not a person, but a corporation is run by people and it affects people. And Kedrion`s business is people. The very nature of our enterprise is to help people live more full and healthy lives. This commitment extends to how we conduct our business, that is, in ways that are consistent with our mission: to build bridges that.benefit people. Long a major player in the plasma derivatives sector in Italy, as partner with the Italian Health System, Kedrion has now become an international participant in the industry with a market presence in about 100 countries. We have plants in Italy, Hungary and the United States and plasma collection centers in the U.S., Germany and Hungary. Kedrion looks forward to continued expansion and the wider sharing of its experience, know-how and technology to foster self-sufficiency of plasma-derived therapies worldwide and to bring healthier and less restricted lives to people suffering from rare disorders. Kedrion Biopharma produces wealth for investors, employees and for the local community, consistent with its own vision and values: responsibility, transparency, confidence in and respect for people. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion Biopharma builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.